Structure

Physi-Chem Properties

Molecular Weight:  532.3
Volume:  550.35
LogP:  3.189
LogD:  2.082
LogS:  -3.81
# Rotatable Bonds:  7
TPSA:  124.04
# H-Bond Aceptor:  8
# H-Bond Donor:  1
# Rings:  4
# Heavy Atoms:  8

MedChem Properties

QED Drug-Likeness Score:  0.532
Synthetic Accessibility Score:  5.128
Fsp3:  0.833
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.182
MDCK Permeability:  4.783152326126583e-05
Pgp-inhibitor:  0.998
Pgp-substrate:  0.034
Human Intestinal Absorption (HIA):  0.015
20% Bioavailability (F20%):  0.024
30% Bioavailability (F30%):  0.899

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.817
Plasma Protein Binding (PPB):  53.43012237548828%
Volume Distribution (VD):  0.379
Pgp-substrate:  37.86654281616211%

ADMET: Metabolism

CYP1A2-inhibitor:  0.004
CYP1A2-substrate:  0.133
CYP2C19-inhibitor:  0.027
CYP2C19-substrate:  0.856
CYP2C9-inhibitor:  0.082
CYP2C9-substrate:  0.056
CYP2D6-inhibitor:  0.002
CYP2D6-substrate:  0.082
CYP3A4-inhibitor:  0.677
CYP3A4-substrate:  0.702

ADMET: Excretion

Clearance (CL):  7.639
Half-life (T1/2):  0.74

ADMET: Toxicity

hERG Blockers:  0.01
Human Hepatotoxicity (H-HT):  0.66
Drug-inuced Liver Injury (DILI):  0.36
AMES Toxicity:  0.011
Rat Oral Acute Toxicity:  0.933
Maximum Recommended Daily Dose:  0.934
Skin Sensitization:  0.082
Carcinogencity:  0.03
Eye Corrosion:  0.433
Eye Irritation:  0.042
Respiratory Toxicity:  0.956

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC77947

Natural Product ID:  NPC77947
Common Name*:   Methyl Lucidenate P
IUPAC Name:   methyl (4R)-4-[(3S,5R,7S,10S,12S,13R,14R,17R)-12-acetyloxy-3,7-dihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoate
Synonyms:   Methyl Lucidenate P
Standard InCHIKey:  PDTQBYSKJSRZCH-YQUZSDLJSA-N
Standard InCHI:  InChI=1S/C30H44O8/c1-15(9-10-22(35)37-8)17-13-21(34)30(7)23-18(32)14-19-27(3,4)20(33)11-12-28(19,5)24(23)25(36)26(29(17,30)6)38-16(2)31/h15,17-20,26,32-33H,9-14H2,1-8H3/t15-,17-,18+,19+,20+,26-,28+,29+,30+/m1/s1
SMILES:  COC(=O)CC[C@H]([C@H]1CC(=O)[C@@]2([C@]1(C)[C@H](OC(=O)C)C(=O)C1=C2[C@@H](O)C[C@@H]2[C@]1(C)CC[C@@H](C2(C)C)O)C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL511952
PubChem CID:   11203394
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001553] Triterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. DOI[10.1016/j.phytochem.2005.10.025]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. fruit body n.a. PMID[11520245]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. PMID[12045343]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. PMID[14695801]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. PMID[1791484]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. spore n.a. PMID[18827358]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota fruiting bodies Nagano, Japan 2008-MAY PMID[20039640]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. PMID[20384295]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota fruiting bodies n.a. n.a. PMID[20702092]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota fruiting bodies n.a. n.a. PMID[21924611]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. PMID[22014750]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. fruit body n.a. PMID[22044278]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota fruiting body n.a. n.a. PMID[22047696]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. PMID[26222905]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. fruit body n.a. PMID[9635497]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT80 Cell Line Raji Homo sapiens Activity = 70.0 % PMID[506168]
NPT520 Cell Line 3T3-L1 Mus musculus Inhibition = 22.0 % PMID[506169]
NPT2 Others Unspecified Activity = 2.3 % PMID[506168]
NPT2 Others Unspecified Activity = 28.9 % PMID[506168]
NPT2 Others Unspecified Activity = 77.4 % PMID[506168]
NPT2 Others Unspecified Activity = 97.6 % PMID[506168]
NPT2 Others Unspecified IC50 = 293.0 molar ratio PMID[506168]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC77947 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC286174
0.9901 High Similarity NPC129689
0.9804 High Similarity NPC115303
0.9505 High Similarity NPC51452
0.95 High Similarity NPC251017
0.9346 High Similarity NPC472927
0.9327 High Similarity NPC272898
0.9327 High Similarity NPC473036
0.9307 High Similarity NPC33973
0.9307 High Similarity NPC70967
0.9216 High Similarity NPC216245
0.9216 High Similarity NPC2436
0.9216 High Similarity NPC470251
0.9216 High Similarity NPC135854
0.92 High Similarity NPC307954
0.9174 High Similarity NPC472933
0.9109 High Similarity NPC124211
0.9065 High Similarity NPC472926
0.9057 High Similarity NPC472928
0.9038 High Similarity NPC473037
0.902 High Similarity NPC53222
0.902 High Similarity NPC281702
0.901 High Similarity NPC299971
0.901 High Similarity NPC157787
0.901 High Similarity NPC144660
0.901 High Similarity NPC88198
0.9 High Similarity NPC121339
0.9 High Similarity NPC122294
0.8952 High Similarity NPC295244
0.8911 High Similarity NPC16021
0.89 High Similarity NPC3772
0.89 High Similarity NPC7124
0.8889 High Similarity NPC472929
0.8846 High Similarity NPC28656
0.8824 High Similarity NPC327431
0.8818 High Similarity NPC472934
0.8812 High Similarity NPC216904
0.8812 High Similarity NPC106557
0.88 High Similarity NPC37646
0.875 High Similarity NPC55872
0.8725 High Similarity NPC112753
0.8725 High Similarity NPC275439
0.8713 High Similarity NPC243525
0.8713 High Similarity NPC40765
0.87 High Similarity NPC184870
0.8679 High Similarity NPC472925
0.8654 High Similarity NPC293753
0.8654 High Similarity NPC308726
0.8654 High Similarity NPC119601
0.8654 High Similarity NPC234892
0.8627 High Similarity NPC43747
0.8627 High Similarity NPC320306
0.8614 High Similarity NPC255809
0.8614 High Similarity NPC297199
0.8584 High Similarity NPC109973
0.8558 High Similarity NPC163372
0.8558 High Similarity NPC302537
0.8529 High Similarity NPC328371
0.8529 High Similarity NPC305483
0.8529 High Similarity NPC328162
0.8529 High Similarity NPC96859
0.8476 Intermediate Similarity NPC56498
0.8462 Intermediate Similarity NPC287833
0.8462 Intermediate Similarity NPC51370
0.8462 Intermediate Similarity NPC205899
0.8455 Intermediate Similarity NPC147180
0.8455 Intermediate Similarity NPC264634
0.8447 Intermediate Similarity NPC18319
0.8431 Intermediate Similarity NPC317586
0.8431 Intermediate Similarity NPC318282
0.8431 Intermediate Similarity NPC173875
0.8431 Intermediate Similarity NPC469995
0.8431 Intermediate Similarity NPC174948
0.8431 Intermediate Similarity NPC470016
0.8416 Intermediate Similarity NPC470254
0.8411 Intermediate Similarity NPC323834
0.8411 Intermediate Similarity NPC181357
0.8396 Intermediate Similarity NPC275583
0.8393 Intermediate Similarity NPC270958
0.8378 Intermediate Similarity NPC202889
0.8378 Intermediate Similarity NPC962
0.8365 Intermediate Similarity NPC10364
0.835 Intermediate Similarity NPC125622
0.835 Intermediate Similarity NPC95565
0.8333 Intermediate Similarity NPC166906
0.8318 Intermediate Similarity NPC96268
0.8317 Intermediate Similarity NPC107690
0.8302 Intermediate Similarity NPC136289
0.8286 Intermediate Similarity NPC472972
0.8286 Intermediate Similarity NPC476274
0.8276 Intermediate Similarity NPC222688
0.8252 Intermediate Similarity NPC241156
0.8252 Intermediate Similarity NPC477438
0.8252 Intermediate Similarity NPC477437
0.8246 Intermediate Similarity NPC118638
0.823 Intermediate Similarity NPC148458
0.823 Intermediate Similarity NPC49492
0.823 Intermediate Similarity NPC266728
0.8224 Intermediate Similarity NPC159442
0.8224 Intermediate Similarity NPC236390
0.8214 Intermediate Similarity NPC250109
0.8208 Intermediate Similarity NPC81530
0.8208 Intermediate Similarity NPC224720
0.8208 Intermediate Similarity NPC476223
0.8208 Intermediate Similarity NPC472924
0.8208 Intermediate Similarity NPC476240
0.8198 Intermediate Similarity NPC34315
0.8182 Intermediate Similarity NPC304495
0.8173 Intermediate Similarity NPC472941
0.8173 Intermediate Similarity NPC456
0.8158 Intermediate Similarity NPC471854
0.8155 Intermediate Similarity NPC477439
0.8137 Intermediate Similarity NPC63748
0.8137 Intermediate Similarity NPC233116
0.8131 Intermediate Similarity NPC473788
0.8131 Intermediate Similarity NPC204450
0.8131 Intermediate Similarity NPC195290
0.8131 Intermediate Similarity NPC80781
0.8131 Intermediate Similarity NPC475558
0.8125 Intermediate Similarity NPC71348
0.8125 Intermediate Similarity NPC170487
0.8125 Intermediate Similarity NPC285956
0.8125 Intermediate Similarity NPC280782
0.8113 Intermediate Similarity NPC198880
0.8113 Intermediate Similarity NPC316964
0.8108 Intermediate Similarity NPC470496
0.8108 Intermediate Similarity NPC197428
0.8108 Intermediate Similarity NPC286880
0.8103 Intermediate Similarity NPC17938
0.8095 Intermediate Similarity NPC23680
0.8091 Intermediate Similarity NPC94529
0.8091 Intermediate Similarity NPC476479
0.8087 Intermediate Similarity NPC21326
0.8077 Intermediate Similarity NPC48330
0.8077 Intermediate Similarity NPC200702
0.8073 Intermediate Similarity NPC196528
0.8073 Intermediate Similarity NPC50535
0.8067 Intermediate Similarity NPC63186
0.8058 Intermediate Similarity NPC25750
0.8058 Intermediate Similarity NPC477435
0.8058 Intermediate Similarity NPC69454
0.8058 Intermediate Similarity NPC477436
0.8056 Intermediate Similarity NPC247957
0.8056 Intermediate Similarity NPC249187
0.8053 Intermediate Similarity NPC25909
0.8039 Intermediate Similarity NPC20388
0.8039 Intermediate Similarity NPC477149
0.8039 Intermediate Similarity NPC477147
0.8036 Intermediate Similarity NPC214797
0.8036 Intermediate Similarity NPC118860
0.8036 Intermediate Similarity NPC188738
0.8036 Intermediate Similarity NPC231589
0.8034 Intermediate Similarity NPC202051
0.8019 Intermediate Similarity NPC197386
0.8019 Intermediate Similarity NPC478056
0.8019 Intermediate Similarity NPC471717
0.8019 Intermediate Similarity NPC114274
0.8018 Intermediate Similarity NPC141350
0.8018 Intermediate Similarity NPC470615
0.8017 Intermediate Similarity NPC475041
0.8017 Intermediate Similarity NPC268958
0.8 Intermediate Similarity NPC144854
0.8 Intermediate Similarity NPC239273
0.8 Intermediate Similarity NPC173272
0.8 Intermediate Similarity NPC42042
0.8 Intermediate Similarity NPC185
0.8 Intermediate Similarity NPC475294
0.8 Intermediate Similarity NPC55296
0.8 Intermediate Similarity NPC3316
0.8 Intermediate Similarity NPC249954
0.7982 Intermediate Similarity NPC72255
0.7982 Intermediate Similarity NPC29705
0.7982 Intermediate Similarity NPC47281
0.7982 Intermediate Similarity NPC473798
0.7982 Intermediate Similarity NPC474181
0.7981 Intermediate Similarity NPC474922
0.7981 Intermediate Similarity NPC245972
0.7981 Intermediate Similarity NPC471720
0.7981 Intermediate Similarity NPC196485
0.7966 Intermediate Similarity NPC269642
0.7965 Intermediate Similarity NPC221144
0.7965 Intermediate Similarity NPC100267
0.7965 Intermediate Similarity NPC475524
0.7963 Intermediate Similarity NPC165250
0.7963 Intermediate Similarity NPC295791
0.7946 Intermediate Similarity NPC76084
0.7946 Intermediate Similarity NPC210005
0.7944 Intermediate Similarity NPC218383
0.7944 Intermediate Similarity NPC471041
0.7944 Intermediate Similarity NPC241221
0.7941 Intermediate Similarity NPC214387
0.7931 Intermediate Similarity NPC257457
0.7931 Intermediate Similarity NPC311554
0.7928 Intermediate Similarity NPC192813
0.7928 Intermediate Similarity NPC275539
0.7928 Intermediate Similarity NPC189075
0.7928 Intermediate Similarity NPC65941
0.7928 Intermediate Similarity NPC154608
0.7928 Intermediate Similarity NPC277017
0.7925 Intermediate Similarity NPC108078

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC77947 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8182 Intermediate Similarity NPD6373 Approved
0.8182 Intermediate Similarity NPD6372 Approved
0.8073 Intermediate Similarity NPD7128 Approved
0.8073 Intermediate Similarity NPD6675 Approved
0.8073 Intermediate Similarity NPD6402 Approved
0.8073 Intermediate Similarity NPD5739 Approved
0.8036 Intermediate Similarity NPD6649 Approved
0.8036 Intermediate Similarity NPD6650 Approved
0.7928 Intermediate Similarity NPD7320 Approved
0.7928 Intermediate Similarity NPD6899 Approved
0.7928 Intermediate Similarity NPD6881 Approved
0.7838 Intermediate Similarity NPD5701 Approved
0.7838 Intermediate Similarity NPD5697 Approved
0.7807 Intermediate Similarity NPD8297 Approved
0.7807 Intermediate Similarity NPD6882 Approved
0.7788 Intermediate Similarity NPD7102 Approved
0.7788 Intermediate Similarity NPD7290 Approved
0.7788 Intermediate Similarity NPD6883 Approved
0.7778 Intermediate Similarity NPD7640 Approved
0.7778 Intermediate Similarity NPD7639 Approved
0.7768 Intermediate Similarity NPD6011 Approved
0.7719 Intermediate Similarity NPD6869 Approved
0.7719 Intermediate Similarity NPD6847 Approved
0.7719 Intermediate Similarity NPD8130 Phase 1
0.7719 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7719 Intermediate Similarity NPD6617 Approved
0.7699 Intermediate Similarity NPD6013 Approved
0.7699 Intermediate Similarity NPD6014 Approved
0.7699 Intermediate Similarity NPD6012 Approved
0.7685 Intermediate Similarity NPD7638 Approved
0.7685 Intermediate Similarity NPD5696 Approved
0.7664 Intermediate Similarity NPD4697 Phase 3
0.7647 Intermediate Similarity NPD6319 Approved
0.7636 Intermediate Similarity NPD7632 Discontinued
0.7596 Intermediate Similarity NPD5328 Approved
0.7593 Intermediate Similarity NPD6083 Phase 2
0.7593 Intermediate Similarity NPD6084 Phase 2
0.7589 Intermediate Similarity NPD6008 Approved
0.7586 Intermediate Similarity NPD4632 Approved
0.757 Intermediate Similarity NPD5695 Phase 3
0.7547 Intermediate Similarity NPD6399 Phase 3
0.7542 Intermediate Similarity NPD6009 Approved
0.75 Intermediate Similarity NPD6672 Approved
0.75 Intermediate Similarity NPD5737 Approved
0.75 Intermediate Similarity NPD5222 Approved
0.75 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD5221 Approved
0.7477 Intermediate Similarity NPD5211 Phase 2
0.7459 Intermediate Similarity NPD7604 Phase 2
0.7458 Intermediate Similarity NPD6868 Approved
0.7453 Intermediate Similarity NPD6079 Approved
0.7438 Intermediate Similarity NPD5983 Phase 2
0.7431 Intermediate Similarity NPD4755 Approved
0.7431 Intermediate Similarity NPD5173 Approved
0.7398 Intermediate Similarity NPD7492 Approved
0.7395 Intermediate Similarity NPD7115 Discovery
0.7355 Intermediate Similarity NPD6059 Approved
0.7355 Intermediate Similarity NPD6054 Approved
0.7345 Intermediate Similarity NPD5141 Approved
0.7339 Intermediate Similarity NPD6336 Discontinued
0.7339 Intermediate Similarity NPD6616 Approved
0.7333 Intermediate Similarity NPD6335 Approved
0.7323 Intermediate Similarity NPD7260 Phase 2
0.7311 Intermediate Similarity NPD6274 Approved
0.7308 Intermediate Similarity NPD3618 Phase 1
0.7297 Intermediate Similarity NPD4700 Approved
0.7297 Intermediate Similarity NPD5285 Approved
0.7297 Intermediate Similarity NPD4696 Approved
0.7297 Intermediate Similarity NPD5286 Approved
0.728 Intermediate Similarity NPD7078 Approved
0.728 Intermediate Similarity NPD8293 Discontinued
0.7273 Intermediate Similarity NPD7101 Approved
0.7273 Intermediate Similarity NPD7100 Approved
0.7266 Intermediate Similarity NPD6845 Suspended
0.725 Intermediate Similarity NPD8295 Clinical (unspecified phase)
0.725 Intermediate Similarity NPD6317 Approved
0.7236 Intermediate Similarity NPD6370 Approved
0.7232 Intermediate Similarity NPD5223 Approved
0.7222 Intermediate Similarity NPD7736 Approved
0.719 Intermediate Similarity NPD6313 Approved
0.719 Intermediate Similarity NPD6314 Approved
0.7179 Intermediate Similarity NPD5955 Clinical (unspecified phase)
0.7177 Intermediate Similarity NPD8328 Phase 3
0.7168 Intermediate Similarity NPD4633 Approved
0.7168 Intermediate Similarity NPD5224 Approved
0.7168 Intermediate Similarity NPD5225 Approved
0.7168 Intermediate Similarity NPD5226 Approved
0.7156 Intermediate Similarity NPD7748 Approved
0.7154 Intermediate Similarity NPD6909 Approved
0.7154 Intermediate Similarity NPD6015 Approved
0.7154 Intermediate Similarity NPD6016 Approved
0.7154 Intermediate Similarity NPD6908 Approved
0.7143 Intermediate Similarity NPD5279 Phase 3
0.713 Intermediate Similarity NPD7515 Phase 2
0.713 Intermediate Similarity NPD6050 Approved
0.713 Intermediate Similarity NPD4767 Approved
0.713 Intermediate Similarity NPD4768 Approved
0.7117 Intermediate Similarity NPD7902 Approved
0.7115 Intermediate Similarity NPD4786 Approved
0.7105 Intermediate Similarity NPD5174 Approved
0.7105 Intermediate Similarity NPD5175 Approved
0.7105 Intermediate Similarity NPD4754 Approved
0.7103 Intermediate Similarity NPD6904 Approved
0.7103 Intermediate Similarity NPD6673 Approved
0.7103 Intermediate Similarity NPD6080 Approved
0.7097 Intermediate Similarity NPD5988 Approved
0.7094 Intermediate Similarity NPD8132 Clinical (unspecified phase)
0.7094 Intermediate Similarity NPD4061 Clinical (unspecified phase)
0.7091 Intermediate Similarity NPD4629 Approved
0.7091 Intermediate Similarity NPD5210 Approved
0.7064 Intermediate Similarity NPD5778 Approved
0.7064 Intermediate Similarity NPD5779 Approved
0.7063 Intermediate Similarity NPD7507 Approved
0.7059 Intermediate Similarity NPD6053 Discontinued
0.7037 Intermediate Similarity NPD5692 Phase 3
0.7034 Intermediate Similarity NPD4634 Approved
0.7016 Intermediate Similarity NPD6291 Clinical (unspecified phase)
0.7009 Intermediate Similarity NPD4729 Approved
0.7009 Intermediate Similarity NPD4730 Approved
0.6981 Remote Similarity NPD7521 Approved
0.6981 Remote Similarity NPD5330 Approved
0.6981 Remote Similarity NPD6409 Approved
0.6981 Remote Similarity NPD6684 Approved
0.6981 Remote Similarity NPD7334 Approved
0.6981 Remote Similarity NPD7146 Approved
0.6972 Remote Similarity NPD5693 Phase 1
0.6972 Remote Similarity NPD8035 Phase 2
0.6972 Remote Similarity NPD5694 Approved
0.6972 Remote Similarity NPD8034 Phase 2
0.6953 Remote Similarity NPD6033 Approved
0.6944 Remote Similarity NPD4753 Phase 2
0.6937 Remote Similarity NPD6356 Clinical (unspecified phase)
0.6923 Remote Similarity NPD5954 Clinical (unspecified phase)
0.6923 Remote Similarity NPD3667 Approved
0.6909 Remote Similarity NPD4202 Approved
0.6899 Remote Similarity NPD7319 Approved
0.6891 Remote Similarity NPD5248 Approved
0.6891 Remote Similarity NPD5251 Approved
0.6891 Remote Similarity NPD5249 Phase 3
0.6891 Remote Similarity NPD5250 Approved
0.6891 Remote Similarity NPD5247 Approved
0.6887 Remote Similarity NPD7520 Clinical (unspecified phase)
0.6864 Remote Similarity NPD5128 Approved
0.6864 Remote Similarity NPD5345 Clinical (unspecified phase)
0.6864 Remote Similarity NPD5168 Approved
0.6863 Remote Similarity NPD6115 Approved
0.6863 Remote Similarity NPD6697 Approved
0.6863 Remote Similarity NPD6118 Approved
0.6863 Remote Similarity NPD6114 Approved
0.6863 Remote Similarity NPD3617 Approved
0.6852 Remote Similarity NPD7513 Clinical (unspecified phase)
0.6852 Remote Similarity NPD6903 Approved
0.6847 Remote Similarity NPD7900 Approved
0.6847 Remote Similarity NPD7901 Clinical (unspecified phase)
0.6822 Remote Similarity NPD6098 Approved
0.6818 Remote Similarity NPD6411 Approved
0.6818 Remote Similarity NPD5284 Approved
0.6818 Remote Similarity NPD5281 Approved
0.6792 Remote Similarity NPD3665 Phase 1
0.6792 Remote Similarity NPD3666 Approved
0.6792 Remote Similarity NPD3133 Approved
0.6789 Remote Similarity NPD7285 Clinical (unspecified phase)
0.6786 Remote Similarity NPD5654 Approved
0.678 Remote Similarity NPD6412 Phase 2
0.6754 Remote Similarity NPD4225 Approved
0.675 Remote Similarity NPD5134 Clinical (unspecified phase)
0.675 Remote Similarity NPD5135 Approved
0.675 Remote Similarity NPD5169 Approved
0.6729 Remote Similarity NPD1694 Approved
0.6729 Remote Similarity NPD5329 Approved
0.6723 Remote Similarity NPD6686 Approved
0.6694 Remote Similarity NPD5217 Approved
0.6694 Remote Similarity NPD5215 Approved
0.6694 Remote Similarity NPD5216 Approved
0.6694 Remote Similarity NPD5127 Approved
0.6667 Remote Similarity NPD5690 Phase 2
0.6667 Remote Similarity NPD5959 Approved
0.6667 Remote Similarity NPD5280 Approved
0.6667 Remote Similarity NPD6117 Approved
0.6667 Remote Similarity NPD4694 Approved
0.6667 Remote Similarity NPD3574 Clinical (unspecified phase)
0.6667 Remote Similarity NPD7637 Suspended
0.6639 Remote Similarity NPD6614 Approved
0.6636 Remote Similarity NPD5764 Clinical (unspecified phase)
0.6636 Remote Similarity NPD6101 Approved
0.6636 Remote Similarity NPD4197 Approved
0.6618 Remote Similarity NPD6333 Approved
0.6618 Remote Similarity NPD6334 Approved
0.6606 Remote Similarity NPD3573 Approved
0.6602 Remote Similarity NPD6116 Phase 1
0.6577 Remote Similarity NPD5207 Approved
0.6577 Remote Similarity NPD5785 Approved
0.6569 Remote Similarity NPD3703 Phase 2
0.6549 Remote Similarity NPD6001 Approved
0.6538 Remote Similarity NPD5784 Clinical (unspecified phase)
0.6532 Remote Similarity NPD5167 Approved
0.6514 Remote Similarity NPD5786 Approved
0.6508 Remote Similarity NPD7328 Approved
0.6508 Remote Similarity NPD7327 Approved
0.6484 Remote Similarity NPD8033 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data